Severe toxicity associated with the combination of tenofovir and didanosine: Case report and review

International Journal of STD and AIDS

Volumn 16, Issue 9, 2005, Pages 646-648

  Masia M ^a   Gutierrez F ^a   Padilla, S ^a   Ramos, J M ^a   Pascual, J ^a  

^a HOSPITAL GENERAL UNIVERSITARIO DE ELCHE   (Spain)

Author keywords

Acute liver failure; Didanosine; Lactic acidosis; Tenofovir; Toxicity

Indexed keywords

ABACAVIR; AMPRENAVIR; DELAVIRDINE; DIDANOSINE; LAMIVUDINE; LOPINAVIR; RITONAVIR; STAVUDINE; TENOFOVIR;

ACUTE KIDNEY FAILURE; ADOLESCENT; ADULT; BODY WEIGHT; BODY WEIGHT DISORDER; CASE REPORT; DISEASE SEVERITY; DRUG BLOOD LEVEL; DRUG DOSE REDUCTION; DRUG EXPOSURE; FEMALE; GUILLAIN BARRE SYNDROME; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERGLYCEMIA; LACTIC ACIDOSIS; LIVER FAILURE; MALE; PANCREATITIS; PRIORITY JOURNAL; REVIEW;

ACIDOSIS, LACTIC; ACUTE DISEASE; ADENINE; ANTI-HIV AGENTS; DIDANOSINE; DRUG THERAPY, COMBINATION; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; LIVER FAILURE; MALE; MIDDLE AGED; PHOSPHONIC ACIDS; REVERSE TRANSCRIPTASE INHIBITORS;

EID: 25844449231     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/0956462054944480     Document Type: Review

References (8)

1. Gallant JE, Deresinski S. Tenofovir disoproxil fumarate. Clin Infect Dis 2003;37:944-50
2. Kearney BP, Damle B, Plummer A, et al. Tenofovir DF and didanosine EC (ddI EC): investigation of pharmacokinetic (PK) drug-drug and drug-food interactions [LbPeB9026]. Presented at the XIV International AIDS Conference, Barcelona, 2002
3. Blanchard JN, Wohlfeiler M, Canas A, King K, Lonergan JT. Pancreatitis with didanosine and tenofovir disoproxil fumarate. Clin Infect Dis 2003;37:57-62
4. Murphy MD, O'Hearn M, Chou S. Fatal lactic acidosis and acute renal failure after addition of tenofovir to an antiretroviral regimen containing didanosine. Clin Infect Dis 2003;36:1082-5
5. Rosso R, Di Biagio A, Ferrazin A, Bassetti M, Ciravegna BW, Bassetti D. Fatal lactic acidosis and mimicking Guillain-Barre syndrome in an adolescent with human immunodeficiency virus infection. Pediatr Infect Dis J 2003;22:668-70
6. Callens S, De Schacht C, Huyst V, Colebunders R. Pancreatitis in an HIV-infected person on a tenofovir, didanosine and stavudine containing highly active antiretroviral treatment. J Infect 2003;47:188-9
7. Rivas P, Polo J, de Gorgolas M, Fernandez-Guerrero ML. Drug points: fatal lactic acidosis associated with tenofovir. BMJ 2003;327:711
8. Kearney BP, Isaacson E, Sayre J, Namini H, Cheng A. Didanosine and tenofovir DF drug-drug interaction: assessment of didanosine dose reduction [533]. Presented at the 10th Conference on Retroviruses and Opportunistic Infections, Boston, 2003